Find clinical trials for Breast Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Phoenix, AZ, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Gilbert, Arizona, United States and 10 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Phoenix, Arizona, United States and 76 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Chandler, Arizona, United States and 226 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Phoenix, Arizona, United States and 52 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...
Phase 2
Phoenix, Arizona, United States and 14 other locations
growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the ...
Phase 1, Phase 2
Phoenix, Arizona, United States and 118 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
Chandler, Arizona, United States and 23 other locations
mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...
Phase 3
Casa Grande, Arizona, United States and 105 other locations
treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.HR-positive breast cancer cells have...
Phase 3
Phoenix, Arizona, United States and 148 other locations
study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast...
Phase 1
Phoenix, Arizona, United States and 73 other locations
Clinical trials
Research sites
Resources
Legal